Record 2025 Performance
Company reported 2025 as a record year for Chemtrade, with management thanking employees for strong results and signalling overall strong full-year performance.
Strong SWC Segment Margin in 2025
SWC (water chemicals) segment delivered EBITDA margins of approximately 23% in 2025, demonstrating robust profitability for the segment despite cost volatility.
Operational Improvements in Regen Acid and Reliability
Regen acid business has shown steady year-over-year improvement in performance and reliability, with management noting ongoing incremental gains and a positive multi-year trend.
Cairo and Tulsa Facility Upgrades Driving Quality and Volume Ramp
Cairo facility approvals are progressing positively with many samples out and management expecting sales volume ramping in H2 2026; Tulsa received targeted upgrades using Cairo learnings to achieve higher quality and potential advanced-node qualification.
Segment Reporting and Visibility Improvement
Water chemicals will be broken out as a separate segment beginning with Q1 2026 reporting (released in May), improving modeling and transparency for revenue, EBITDA and margins by segment.
Capital Expenditure Framework and LTIP Guidance
Sustaining capital expected around $120M–$130M annually; growth CapEx guidance of roughly $35M–$50M (management noted $35M–$50M of growth CapEx does not include potential North Vancouver rezoning-related spend). Long-term incentive (LTIP) guidance provided in a $22M–$28M range for modeling.